Patents by Inventor Tomoyuki Konda

Tomoyuki Konda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220393443
    Abstract: To safely start and operate electrical devices accommodated in a local electrical room located in a hazardous area, a plant module (2) includes: a group of plant equipment (6) that constitutes a plant; a local electrical room (5) located in a hazardous area (31) defined by presence of combustible gas and accommodating a power device configured to supply electric power to the group of plant equipment (6); a structure (21) supporting the group of plant equipment (6) and the local electrical room (5); and an outside air supply device (64) having explosion-proof properties and arranged at the local electrical room (5) to supply outside air to an inside thereof, wherein the plant module (2) is configured to supply the electric power to the outside air supply device (64) from a non-hazardous area.
    Type: Application
    Filed: November 13, 2019
    Publication date: December 8, 2022
    Inventors: Satoshi YASUDA, Tomoyuki KONDA
  • Publication number: 20100093973
    Abstract: Herein disclosed is a water-soluble compound represented by the following general formula (I) or a salt thereof. The compound is a novel water-soluble compound having an inhibitory effect on the absorption of phosphorus in vivo. where the structural variables are defined herein.
    Type: Application
    Filed: August 27, 2009
    Publication date: April 15, 2010
    Applicant: AJINOMOTO CO., INC.
    Inventors: Tadakiyo Nakagawa, Hironobu Tsugeno, Naomi Matsutani, Masayuki Sugiki, Haruko Hirashima, Tatsuya Okuzumi, Tatsuya Kasahara, Wataru Miyanaga, Takashi Yamamoto, Masatsugu Noguchi, Kayo Matsumoto, Hideyuki Tanaka, Tomoyuki Konda
  • Publication number: 20080249001
    Abstract: The present invention provides improving agents of side-effects of chemotherapy agents. Though the erythroid progenitor cells decrease due to the side-effect of chemotherapy agents, such side-effect can be improved by chemotherapy agents which comprise arginine as the active ingredient.
    Type: Application
    Filed: October 25, 2007
    Publication date: October 9, 2008
    Applicant: AJINOMOTO CO. INC.
    Inventors: Akiko Onuki, Kazumi Tashiro, Yuzuru Eto, Tomoyuki Konda